IMR Press / CEOG / Volume 37 / Issue 4 / pii/1630630915623-986615578

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 46 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Editorial
The multiple uses of ethinyl estradiol for treating infertility
Show Less
1 The University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Cooper Hospital/University Medical Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, NJ (USA)
Clin. Exp. Obstet. Gynecol. 2010, 37(4), 249–251;
Published: 10 December 2010
Abstract

Purpose: To demonstrate the usefulness of ethinyl estradiol, a drug no longer commercially produced in most countries, in treating various fertility related issues. Methods: Twenty to 40 micrograms of ethinyl estradiol can be started on day 2 or 3 of the cycle and combined with exogenous gonadotropin can be useful in improving hostile cervical mucus or inducing ovulation in women with hypergonadotropic amenorrhea. It can be used from the day after stopping clomiphene citrate to help negate the adverse effect of this drug on cervical mucus. Results: Successful pregnancies have been achieved saving the couple the expense of intrauterine insemination (IUI) or using donor oocytes. Conclusions: This drug can be very helpful for those physicians who treat each infertile woman on an individual basis and carefully ascertain the couple’s input as to their preferences rather than a “herd” type of medicine.
Keywords
Ethinyl estradiol
Postcoital test
Clomiphene citrate
Premature ovarian failure
Premature luteinization
Share
Back to top